GlassScriptPhysician profile
Susan T Butler
NPI 1013118843
$2,080.87
in general payments reported to CMS, 2019-2025
17 companies · $1,235 in 2025
The $1,235 reported for 2025 was more than what 79% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.28 · 2022: $141 · 2023: $265 · 2024: $423 · 2025: $1,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,908 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.59 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $371.96 | 2024-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $313.89 | 2022-2025 | Dupixent |
| Incyte Corporation | $265.96 | 2025 | Opzelura |
| Lilly USA, LLC | $184.74 | 2024-2025 | Taltz, Ebglyss |
| Arcutis Biotherapeutics, INC. | $154.10 | 2024-2025 | Zoryve |
| Abbvie INC. | $149.68 | 2022-2025 | Rinvoq, Skyrizi |
| Galderma Laboratories, L.P. | $140.25 | 2025 | Nemluvio |
| Genzyme Corporation | $130.57 | 2022-2025 | |
| Organon LLC | $111.50 | 2025 | Vtama |
| Janssen Biotech, INC. | $62.41 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $44.21 | 2025 | |
| Pfizer INC. | $34.46 | 2023 | |
| Ucb, INC. | $33.17 | 2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $27.54 | 2023 | Sotyktu |
| Leo Pharma INC. | $20.29 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipher Pharmaceuticals US LLC | $18.86 | 2025 | Natroba, Spinosad |
| Urogen Pharma, INC. | $17.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.